Group One Trading’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$489 Buy
+150
New +$745 ﹤0.01% 7322
2024
Q3
Sell
-25
Closed -$3.5K 7249
2024
Q2
$3.5K Sell
25
-239
-91% -$32.6K ﹤0.01% 6087
2024
Q1
$55.9K Buy
264
+120
+83% +$32.4K ﹤0.01% 4630
2023
Q4
$36.5K Sell
144
-216
-60% -$59.2K ﹤0.01% 5309
2023
Q3
$129K Buy
+360
New +$54.7K ﹤0.01% 4216
2022
Q4
Sell
-25
Closed -$4K 7953
2022
Q3
$4K Sell
25
-94
-79% -$17.1K ﹤0.01% 6950
2022
Q2
$18K Buy
119
+34
+40% +$15.6K ﹤0.01% 6370
2022
Q1
$56K Buy
85
+71
+507% +$37.8K ﹤0.01% 6008
2021
Q4
$8K Buy
+14
New +$10.2K ﹤0.01% 7470

Other funds holding LNAI

Group One Trading's LNAI Position: Q1 2026 in Review

Group One Trading increased its Lunai Bioworks (LNAI) stake by 134% in Q1 2026, buying an estimated $1.55K and bringing the position to 545 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #7085.

Group One Trading first reported a position in LNAI in Q3 2021 and has held it in 8 quarters since. The position peaked at $14K in Q4 2021. 27 funds tracked by Wall St. Rank hold LNAI as of Q1 2026.

  • Group One Trading held 545 shares of Lunai Bioworks worth $1.78K as of Q1 2026.
  • Group One Trading bought 312 Lunai Bioworks shares in Q1 2026, an estimated $1.55K.
  • Lunai Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7085 holding.
  • Group One Trading first reported a position in Lunai Bioworks in Q3 2021 and has held it in 8 quarters since.
  • Group One Trading's Lunai Bioworks position peaked at $14K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.